CME | CME GroupNASDAQFinancialCommon stock golden cross and death cross projections, cross tests and history

$304.06
-$2.18 (-0.71%)

CME Group (CME) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2019.

The 50 SMA has sat above the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $304.06 vs 50 $281.46 / 200 $280.48
Projection
No cross projected
Test
Cross test window open, no test bar yet
Last cross
Golden cross 30 Oct 2026 ยท projected 18 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $303.14 vs 50 $279.51 / 200 $236.93
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 1 Jan 2024 ยท projected 16 bars out ยท tested 2 bars

4-hour as of 3 Nov 16:00 ET

Price
above both $304.06 vs 50 $287.37 / 200 $267.00
Projection
No cross projected
Test
No active test
Last cross
Golden cross 28 Aug 2026 ยท projected 18 bars out

Cross history

31
crosses on record since 2019
16 golden15 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
30 Oct 2026Golden steepdaily18 bars outActive Cross Test
28 Aug 2026Golden4-hour18 bars outNot tested
17 Jun 2026Death steepdaily27 bars outNot tested
7 May 2026Death4-hour30 bars outNot tested
20 Nov 2025Golden moderatedaily10 bars outNot tested

About CME

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$483M
4-hour coverageYes, since Oct 2025
History on recordSince 2019
SectorFinancial
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.